Cannabis Insights

September 22, 2018

Navigating the Maze of the Cannabis Market After the Daze of Summer

By J.J. McCoy, Senior Managing Editor, for New Frontier Data Even before word of the DEA’s landmark rescheduling of cannabidiol (CBD) for GW Pharmaceutical’s FDA-approved Epidiolex, […]